Mohammed (Mo) Ali is currently the global lead for digital development at Boehringer Ingelheim Pharmaceuticals. Prior to this role, he served as a Director within the R&D Operations and Innovations group at J&J Pharmaceuticals and also within the digital development group and Strategic Program Office at Novartis, responsible for several "E" initiatives within Digital Health. These programs aim to serve the needs of patients by creating a digital footprint and platform which would assist in the overall tracking, delivery and enrichment of the their wellness management.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)